⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BFRI News
Biofrontera Inc. Common Stock
Form 8-K
sec.gov
BFRI
BFRIW
Biofrontera Inc. Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides a Business Update
globenewswire.com
BFRI
Biofrontera Inc. to Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call on March 19, 2026
globenewswire.com
BFRI
Biofrontera Inc. to Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call on March 19, 2026
globenewswire.com
BFRI
Form 8-K
sec.gov
BFRIW
BFRI
Biofrontera Inc. Reports Positive Phase 2b Results Supporting Further Development of Ameluz® Photodynamic Therapy for moderate to severe Acne Vulgaris
globenewswire.com
BFRI
Biofrontera Inc. Reports Positive Phase 2b Results Supporting Further Development of Ameluz® Photodynamic Therapy for moderate to severe Acne Vulgaris
globenewswire.com
BFRI
BFRIW
Form 8-K
sec.gov
BFRIW
BFRI
U.S. Patent Office Issues Final Written Decision Finding All Challenged Claims of Sun Pharma’s Patent 11,697,028 To Be Unpatentable
globenewswire.com
BFRI
BFRIW
Biofrontera Inc. Announces Database Lock of Phase 1 Pharmacokinetics Study of Ameluz® for Actinic Keratoses on Trunk and Extremities
globenewswire.com
BFRI
BFRIW